Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Neurosteroids are reported to exert anti‐inflammatory effects in several neurological disorders. We investigated the expression and actions of the neurosteroid, dehydroepiandrosterone (DHEA), and its more stable 3β‐sulphated ester, DHEA‐S, in MS and associated experimental models. CNS tissues from patients with MS and animals with experimental autoimmune encephalomyelitis (EAE) displayed reduced DHEA concentrations, accompanied by diminished expression of the DHEA‐synthesizing enzyme CYP17A1 in oligodendrocytes (ODCs), in association with increased expression of inflammatory genes including interferon (IFN)‐γ and interleukin (IL)‐1β. CYP17A1 was expressed variably in different human neural cell types but IFN‐γ exposure selectively reduced CYP17A1 detection in ODCs. DHEA‐S treatment reduced IL‐1β and −6 release from activated human myeloid cells with minimal effect on lymphocyte viability. Animals with EAE receiving DHEA‐S treatment showed reduced Il1b and Ifng transcript levels in spinal cord compared to vehicle‐treated animals with EAE. DHEA‐S treatment also preserved myelin basic protein immunoreactivity and reduced axonal loss in animals with EAE, relative to vehicle‐treated EAE animals. Neurobehavioral deficits were reduced in DHEA‐S‐treated EAE animals compared with vehicle‐treated animals with EAE. Thus, CYP17A1 expression in ODCs and its product DHEA were downregulated in the CNS during inflammatory demyelination while DHEA‐S provision suppressed neuroinflammation, demyelination, and axonal injury that was evident as improved neurobehavioral performance. These findings indicate that DHEA production is an immunoregulatory pathway within the CNS and its restoration represents a novel treatment approach for neuroinflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain
Mellon, S. H., & Deschepper, C. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91332-m · Cited by 398
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191 · cited 2×
“…remain uncertain although inflammatory molecules including cytokines, chemokines, prostaglandins, reactive oxygen species (Caruso et al., 2014; Lassmann, 2014) and proteases have been implicated in demyelination and axonal/ neuronal injury (Huber & Irani, 2015; Lam et al., 2016; Radbruch et…”
BackgroundDevelopment and homeostasis of “resident” myeloid cells: the case of the microglia
Gomez Perdiguero, E., Schulz, C., & Geissmann, F. (2013) · Glia · doi:10.1002/glia.22393 · Cited by 182
Mháille, A. N., McQuaid, S., Windebank, A., Cunnea, P., McMahon, J., Samali, A., & FitzGerald, U. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318165b239 · Cited by 128
El-Etr, M., Rame, M., Boucher, C., Ghoumari, A. M., Kumar, N., Liere, P., Pianos, A., Schumacher, M., & Sitruk-Ware, R. (2015) · Glia · doi:10.1002/glia.22736 · Cited by 116 · cited 1×
“…of steroid biology in the brain and links to pathways implicated in inflammation and cell survival (Arbo, Benetti, & Ribeiro, 2016; Chatzopoulou et al., 2016; El-Etr et al., 2015; Gorska, Kuban-Jankowska, Milczarek, & Wozniak, 2016; Hirahara et al., 2013; Patel & Katyare, 2006; Weng & Chung, 2016).”
BackgroundQuantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation
Wang, Y. V., Wade, M., Wong, E., Li, Y.-C., Rodewald, L. W., & Wahl, G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701497104 · Cited by 116 · cited 1×
“Immunoreactivity was quantified by using the Odyssey Infrared Imaging System (LI-COR) and represented graphically (Wang et al., 2007).”
MethodKhan, R. S., Dine, K., Luna, E., Ahlem, C., & Shindler, K. S. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-14672 · Cited by 33
Cited by
McKenzie, B. A., Mamik, M. K., Saito, L. B., Boghozian, R., Monaco, M. C., Major, E. O., Lu, J.-Q., Branton, W. G., & Power, C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722041115 · Cited by 514
Self-citationExtra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders
Slominski, R. M., Tuckey, R. C., Manna, P. R., Jetten, A. M., Postlethwaite, A., Raman, C., & Slominski, A. T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0096-6 · Cited by 155
Pollock, N. M., Fernandes, J. P., Woodfield, J., Moussa, E., Hlavay, B., Branton, W. G., Wuest, M., Mohammadzadeh, N., Schmitt, L., Plemel, J. R., et al. (2024) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.10.022 · Cited by 21
Self-citationSaito, L. B., Fernandes, J. P., Smith, M. J., Doan, M. A. L., Branton, W. G., Schmitt, L. M., Wuest, M., Monaco, M. C., Major, E. O., Wuest, F., et al. (2021) · Glia · doi:10.1002/glia.23896 · Cited by 18
Self-citationScalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10
Metadata
- Authors
- Boghozian, R., McKenzie, B. A., Saito, L. B., Mehta, N., Branton, W. G., Lu, J., Baker, G. B., Noorbakhsh, F., & Power, C.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2017-07-14
- Volume
- 65
- Issue
- 10
- Pages
- 1590-1606
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2735193465
- Cited by
- 45
- References
- 7
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation. https://app.cochat.ai/papers/10.1002/glia.23179
- The paper
- Boghozian, R., McKenzie, B. A., Saito, L. B., Mehta, N., Branton, W. G., Lu, J., Baker, G. B., Noorbakhsh, F., & Power, C. (2017). Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation. Glia. https://doi.org/10.1002/glia.23179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.